- Di we aw pipul dɛn de liv dɛn layf ɛn di we aw dɛn de it kin chenj
- Ɛksasayz
- Mɛrɛsin dɛn we dɛn kin yuz
Aw dɛn mɛrɛsin ya fɔ gɛt dayabitis kin rili wok?
Fɔ tɔk am simpul wan, di men gol fɔ ɔl dɛn mɛrɛsin ya na fɔ mek yu blɔd shuga, ɔ ``blɔd glukɔs,'' go dɔŋ to wan wɛlbɔdi lɛvɛl. Dis de ɛp bak fɔ kɔntrol yu ``A1c'' valyu. Insulin resistance na di men tin we kin mek pɔsin gɛt tayp 2 dayabitis (ɛn gestational diabetes).Wan kכndyushכn we dεn kכl `insulin rεsistεns`. imajin, di sεl dεm na yu bכdi (yu mכsul dεm, fεt, εn liva sεl dεm) nכ de rεspכnd fayn to di כmon `insulin`. Insulin na sɔntin we yu pankrias de mek. I de tɔn di shuga `glukɔs` frɔm di it we wi de it to ɛnaji. Dis na tin we rili impɔtant fɔ mek wi kɔntinyu fɔ liv. So, we yu gɛt insulin rɛsistɛns, yu pankrias gɛt fɔ mek mɔ insulin fɔ kɔntrol di shuga we yu gɛt na yu blɔd. Bɔt we yu pankrias nɔ ebul fɔ mek insulin, yu blɔd shuga kin go ɔp. Dis na wetin wi kin kɔl ay blɔd shuga lɛvɛl `haypa glycemia`. If dis kɔntinyu, i kin mek wi gɛt difrɛn wɛlbɔdi prɔblɛm dɛn. Insulin resistance na tin we kɔmplikt smɔl. Di mɛrɛsin fɔ dayabitis kin wok difrɛn we dɛn fɔ mek di blɔd shuga go dɔŋ. Sɔm mɛrɛsin dɛn kin ɛp yu pankrias fɔ mek mɔ insulin. Apat frɔm di mɛrɛsin dɛn, ɛksesaiz impɔtant bak fɔ mek yu nɔ gɛt insulin.Wetin na di mɛrɛsin dɛn we dɛn kin tek fɔ it fɔ dayabitis?
Bɔku kayn mɛrɛsin dɛn de we kin ɛp fɔ kɔntrol dayabitis, ɛn dɛn kin wok difrɛn we dɛn. Lɛ wi tek wan luk pan wetin dɛn bi:| Kategori fɔ drɔgs | Aw i de wok | Ɛgzampul dɛn |
|---|---|---|
| Alfa-glukosidayz inhibitɔ dɛn | I de kɔntrol di we aw di kabɔhaydrɛt ɛn shuga we de na di insay de brok. | `Akarboz`, `Miglitol` |
| Biguanides we dɛn kɔl | i de ridyus di glukכs we di liva de mek, i de mek di insulin sεnsitiviti bכku. | `Mɛtfɔmin` |
| Bayl asid sikwεstrant dεm | Pan ɔl we i de mek di kɔlɔstrel go dɔŋ, i de mek di shuga we de na di blɔd go dɔŋ bak. | `Kɔlsevelam` |
| Dopamin-2 agonist dɛn we dɛn kin yuz | I de inflɔws di bren fɔ ridyus di insulin rɛsistɛns. | `Brɔmokriptin` |
| DPP-4 inhibito dεm (Gliptins) . | Di GLP-1 ɔmon de kip di blɔd shuga in chɛk bay we i de kip am aktif. | Alogliptin, Linagliptin, Saksagliptin, Sitagliptin |
| Meglitinid dɛn (Glinid dɛn) . | I de mek di pankrias wok ɛn mek i pul insulin. | `Nateglinide`, `Rɛpaglinid` |
| SGLT2 inhibito dεm | εkstra glukכs de kכmכt na di urine. | ``Kanagliflɔzin'', ``Dapagliflɔzin'', ``Ɛmpagliflɔzin''. |
| Sɔlfɔnilɔria dɛn | I de mek di pankrias wok ɛn mek i pul mɔ insulin. | ``Glimepiride'', ``Glipizayd'', ``Glayburayd'', ɛn di ɔda wan dɛn we de na di wɔl. |
| Tiazolidindiɔn (TZD) dɛn . | I de mek di tisu dɛn sɛnsitiv mɔ to insulin. | ``Rosiglitazone'', ``Pioglitazone'', di wan we de mek di sik. |
Wetin na di sayd ɛfɛkt dɛm we di mɛrɛsin fɔ dayabitis kin gɛt?
Lɛk ɔl di mɛrɛsin dɛn, di mɛrɛsin fɔ dayabitis kin gɛt sayd ɛfɛkt. Ɛni mɛrɛsin kin mek wi gɛt difrɛn prɔblɛm dɛn. di sayd ifekt dεm we kin kכmכn pas כl na di gεstrointestinal prכblεm (dεya, kכnstipshכn, blo). Di tin we impɔtant pas ɔl na fɔ tɛl yu dɔktɔ bɔt ɛni bad bad tin we go apin to yu.Risk fɔ gɛt haypoglycemia
Sɔm dayabitis mɛrɛsin, mɔ di wan dɛn we dɛn kɔl `Meglitinides` ɛn `Sulfonylureas`, kin mek yu blɔd shuga lɛvɛl go dɔŋ wantɛm wantɛm (hypoglycemia). Dis na we yu blɔd shuga de drɔp dɔŋ 70 mg/dL. Dis na siriɔs kɔndishɔn.Di sayn dɛm wae de sho se yu gɛt haypoglycemia: yu kin shek, yu kin swet, yu kin gɛt ed, yu kin angri pasmak, yu nɔ kin rɛst, ɛn yu at kin bit kwik kwik wan. If dɛn sik ya apin, it sɔntin we gɛt shuga ɔ kabɔhaydrɛt wantɛm wantɛm.
Tin dɛn fɔ tɔk to yu dɔktɔ
- Bɛlɛ : If yu gɛt bɛlɛ ɔ yu de plan fɔ gɛt bɛlɛ, i impɔtant fɔ tɔk bɔt yu mɛrɛsin wit yu dɔktɔ. Bɔku pan di mɛrɛsin dɛn we dɛn kin tek bay mɔt, pas fɔ Metformin , dɛn nɔ kin advays am we uman gɛt bɛlɛ .
- Ɔda mɛrɛsin dɛn: Tɛl yu dɔktɔ bɔt ɔl di ɔda mɛrɛsin dɛn, vaytamɛn dɛn , ɛn sɔpɔtmɛnt dɛn we yu de tek.
- Sayd ɛfɛkt: Tɛl yu dɔktɔ bɔt ɛni sayd ɛfɛkt we yu gɛt.
💬 Comments (0)
No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.
Ad yu kɔmɛnt